Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Studio Clinico Randomizzato Per Valutare l'Efficacia Del Bifidobacterium BB-12® Nel Trattamento Delle Coliche Infantili

NCT03434249 is registered in ClinicalTrials.gov with SOFAR S.p.A. as lead sponsor.

NCT NCT03434249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03434249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Studio Clinico Randomizzato Per Valutare l'Efficacia Del Bifidobacterium BB-12® Nel Trattamento Delle Coliche Infantili
Lead sponsor
SOFAR S.p.A.
Phase
Not applicable
Overall status
Completed
Start date
November 11, 2016
Completion date
November 6, 2017
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colic, infantile, infantile colic